November 8, 2009
Pharmacosmos participates in the XIX FIGO World Congress of
Gynecology & Obstetrics 2009. The congress is held in Cape
Town, South Africa from 4th to 9th October 2009. For further
information about the congress, we refer to www.figo2009.org.za.
About Pharmacosmos A/S
Pharmacosmos develops and markets
medicines for the treatment of iron deficiency. A research-based
company, its ongoing R&D programme focuses on improving the
treatment options for healthcare professionals and patients
suffering from iron deficiency.
Pharmacosmos is a privately-owned
company and operates in more than 50 countries across Europe, the
Americas and Asia. All its manufacturing is approved by the Danish
Medicines Agency and the US Food & Drug Administration.